NLS Pharmaceutics AG: NLS Pharmaceutics To Host Virtual Key

ZURICH, SWITZERLAND / ACCESSWIRE / September 19, 2022 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP), (Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery

Related Keywords

Switzerland , Zurich , Züsz , Danville , Ohio , United States , Cincinnati , Swiss , Alex Zwyer , Bruce Corser , Anne Marie Morse , George Apostol , Cindy Rizzo , Pascal Nigen , Novant Health , Geisinger Medical Center , Nasdaq , Pharmaceutics Ltd , Exchange Commission , Alpha Bronze , Management Institute , European Medicines Agency , Virtual Key Opinion Leader , Chief Medical Officer , Global Head , Medical Director , Sleep Management Institute , Sleep Medicine , Marie Morse , Pediatric Neurology , Advanced Respiratory , Epworth Sleepiness Scale , Orphan Disease Designation , Mazindol Controlled Release , Orphan Drug Designations , Pharmaceutics , Most , Irtual , Opinion , Leader , Event , September , 022 , After , Release , Uilience , Line , Hase , Narcolepsy , Results ,